(S)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride is primarily utilized in pharmaceutical research as a chiral building block for the synthesis of biologically active compounds. Its structure makes it valuable in the development of potential therapeutic agents, particularly in the field of central nervous system (CNS) disorders. Researchers explore its use in creating molecules that may interact with neurotransmitter systems, such as dopamine or serotonin receptors, to address conditions like depression, anxiety, or Parkinson's disease. Additionally, its chiral nature allows for the study of enantiomer-specific effects, which is crucial in optimizing drug efficacy and reducing side effects. This compound also serves as a key intermediate in organic synthesis, enabling the creation of complex molecules for medicinal chemistry and drug discovery projects.